Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 22, Issue 1, Pages 319-322Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2011.11.005
Keywords
Mitochondrial voltage sensor; Myocardial perfusion agent; [F-18]-labeled; Phosphonium salt; Positron emission tomography (PET)
Categories
Funding
- National Research Foundation of Korea (NRF) [2010-0028750]
- Bio RD program [2010-0020658]
- Bioimaging Research Center at GIST
- Korean Ministry of Education, Science and Technology
Ask authors/readers for more resources
[F-18]-labeled molecular probe for the detection of myocardial perfusion deficit is driving particular interest due to its high clinical applicability. Thus, we synthesized (2-(2-[F-18] fluoroethoxy) ethyl) triphenylphosphonium salt ([F-18] 3) that specifically accumulates in myocardium according to mitochondrial membrane potential. Here, we evaluated the performance of [F-18]3 as a mitochondrial voltage sensor in vitro and in vivo. The [F-18]3 was synthesized with 20 similar to 30% radiochemical yield and radiochemical purity was >98% by analytical HPLC. Specific activity was >6.7 TBq/mu mol. The cellular uptake assay showed preferential uptake of [F-18]3 in cardiomyocytes. The results of biodistribution and micro-PET imaging studies of [F-18]3 in mice and rats showed preferential accumulation in the myocardium. The results suggest that this compound would be a promising candidate for myocardial imaging. (C) 2011 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available